CLL study tracks Long-Term survival after First-Line treatment
NCT ID NCT06792994
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study follows 2,000 people with chronic lymphocytic leukemia (CLL) who have completed first-line treatment in earlier clinical trials. Researchers will collect data from routine care to see how different treatment sequences affect overall survival, quality of life, and safety over time. The goal is to learn what factors help patients live longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors understand which treatment sequences work best for long-term survival in CLL patients.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and depend on real-world data quality.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Cologne
RECRUITINGCologne, 50924, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Ulm
RECRUITINGUlm, 89081, Germany